PANNONE LOPES DEVEREAUX & O'GARA LLC

Lobbying for AMGEN · Biotechnology company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · $9,000.00 income · posted Nov 6, 2025

Lobbying activity 1

Pharmacy

Prescription drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem